Despite improved diagnostic and innovative surgical techniques, infectious
complications remain a leading cause of death in patients with genital canc
er. With changing therapeutic approaches in gynecologic oncology, the natur
e of infections has changed. This article focuses on the current trends in
the management of infectious diseases in the patient with gynecologic cance
r.